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The use of mechanical circulatory support is considered 
standard care for postcardiotomy cardiogenic shock 
that is both drug and intra-aortic balloon pump refrac- 
tory, as well as in the bridge-to-transplant, applica- 
tion.' In the postcardiotomy application, the patient 
can be supported with either a right (RVAD) or left 
ventricular assist device (LVAD), or with two devices in 
the case of severe biventricular failure. The goals are to 
provide adequate systemic and/or pulmonary blood 
flow while unloading the failing ventricle until myocar- 
dial recovery occurs, at which time the device(s) is 
explanted. In the rare instance of device dependency 
and the absence of contraindications to orthotopic 
heart transplant, bridge-to-transplantation may be a 
further option. In the bridge-to-transplant application, 
a potential cardiac transplant recipient who deterio- 
rates hemodynamically before the availability of a 
donor organ can be likewise supported until such 
becomes available. Obviously, the goals are somewhat 
different. The device(s) allows for support of the 
circulation with rehabilitation potential; however, car- 
diac function is not expected to return. 
Overview of the System 
The Thoratec VAD (Thoratec, Pleasanton, CA) repre- 
sents the only system currently approved in the United 
States for both of the previously mentioned applica- 
tions. This paracorporeal device has a great deal of 
flexibility in that it can be configured for univentricu- 
lar, right- or left-sided, or biventricular support (Fig 
LA-D).'J Furthermore, inflow cannulation can be via 
the atria or ventricle using the appropriate cannulae 
(Fig 11). The paracorporeal location allows for use in 
the small patient (0.7 m2 body surface area). The 
prosthetic ventricle consists of a machined polycarbon- 
ate housing of an angle port design containing a seam- 
free proprietary segmented polyurethane sac (Fig 111). 
The pumping chamber is separated from the air cham- 
ber by a polyurethane diaphragm, which serves both as 
a volume limiter and a safety chamber. The VAD uses 
monostrut inlet and outlet valves to provide unidirec- 
tional flow (Fig IV). Systemic anticoagulation is there- 
fore necessary. Alternating pulses of pressure and 
vacuum, delivered by a dual-drive console via an 8- or 
12-foot pneumatic lead, empty and fill the blood sac. 
The stroke volume is approximately 65 mL. A Hall 
effect switch built into the polycarbonate case indicates 
complete filling of the device. The dual-drive console 
has two independent drive modules, each of which is 
designed to drive one ventricle or provide backup safety 
in the case of univentricular support (Fig V). Recently, 
Thoratec has developed the TLC-I1 (Pleasanton, CA), a 
compact and lightweight (9-kg) portable drive unit 
designed to promote management with either uni- or 
biventricular support (Fig V). Regardless, these drive 
units can be operated in a fixed asynchronous mode 
chosen by the operator or in a volume, or automatic mode, 
where changes in flow output occur in response to 
changes in physiological conditions. This mode is a variable- 
rate fixed-stroke volume, or full-to-empty pattern, where 
the instant the blood pump is full, the fill switch signals 
the driver to eject. The rate varies with the preload (ie, 
atrial or ventricular inlet pressure) and allows for a 
full-to-empty operation from 20 to 110 beats per minute 
or outputs ranging from approximately 1.3 to 7.1 L/min . 
Next is described the techniques for cannulation and 
implantation of the Thoratec system, which was initially 
developed at our institution as the Pierce-Donachy VAD 
and was first clinically used in 1976.3 
Preparing for Cardiopulmonary Bypass 
and General Considerations for Insertion 
of Thoratec VAD 
For LV support, inflow cannulation can be via the left 
atrial appendage, intra-atrial groove, left atrial roof, or 
ventricular apex. Generally, atrial inflow cannulation is 
preferred in the recovery situation postcardiotomy 
because insertion avoids further myocardial damage 
and removal does not require cardiopulmonary bypass 
(CPB). In fact, under certain circumstances, the device 
may even be inserted without CPB. However, the 
thromboembolic rate is likely higher, and this mode 
should be avoided with prosthetic mitral valves to 
prevent ventricular thrombosis. Currently, the atrial 
inflow cannula is a 51F right-angled venous return cannula 
coated with proprietary segmented polyurethane. LV 
apical inflow is the method of choice in the bridge-to- 
transplant application because maximal reduction in 
wedge pressures and, therefore, pulmonary artery 
pressures and pulmonary vascular resistance, occurs. 
The additional LV damage is inconsequential because 
recovery is not expected. Thromboembolic rates are lower. 
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Fig I. The various and most commonly used approaches for the Thoratec VAD. (A) Biventricular 
support using apical ventricular and right atrial inflow cannulation. This is a popular and useful 
method for bridge-to-transplantation, although, recently, we have favored RV inflow cannulation. 
(B) Biventricular support using biatrial inflow cannulation. This is commonly used in the 
postcardiotomy application. A curved right atrial inflow cannula facilitates this configuration. (C) 
Biventricular support using biventricular inflow. This offers the advantage of higher flows in our 
experience. (D) Univentricular configuration using inflow cannulation via the base of the left atrial 
appendage. Note that it is possible at times to perform insertion without CPB when using atrial 
inflow cannulation via the interatrial groove. 
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Fig 11. The Thoratec cannulae that we commonly use are depicted. At 
the top, the long right-angled atrial inflow cannula. Pictured in the 
middle is the composite polyurethane and Dacron graft outflow cannula 
that is anastomosed to the aorta or pulmonary artery. At the bottom is 
the ventricular inlet cannula (bevel-tipped model). We generally prefer 
the blunt-ended type, with the intraventricular portion covered with 
velour. 
Fig 111. The prosthetic ventricle is shown with the black 
colletnut on inflow housing and white colletnut on outflow 
housing. The fill switch can been seen in the middle of the 
housing of the ventricle and the electrical and pneumatic 
connection at  the bottom. 
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Fig IV. Artist's rendition of a cut-a-way of the prosthetic ventricle 
with a rigid polycarbonate housing enclosing a seam-free proprietary 
segmented polyurethane sac. Monostrut inlet and outlet valves provide 
unidirectional flow when pulses of air are delivered between the outer 
case and the stroke-limiting diaphragm. 
Fig V. To the right of the patient is the dual-drive console 
contrasting, with the portable TLC-I1 (Thoratec) slung from 
the patient's left shoulder. The portable driver has biventricu- 
lar pumping capabilities and provides for improved patient 
mobility. 
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Fig VI. The ventricular cannula with the combination cannula 
pluglsuction connector. When the screw-on cap of the combination 
cannula plug/suction connector is removed, connection is made to 
cardiotomy suction, allowing for venting of the heart and deairing via 
the inflow cannula. Below is the tunneler, which facilitates bringing 
the cannula from its pericardial target site out through the skin with 
minimal dissection, thus, keeping the surrounding tissue in tight 
approximation to minimize dead space and allowing for tissue 
ingrowth. The bullet tip and end-cap are removable. 
For RV support, inflow uses the same cannulae as for 
left-sided applications and can be via the right atrium 
or RV with the latter providing higher flows. 
The outflow cannula, regardless of the application, is 
a composite proprietary segmented polyurethane con- 
duit with an attached l4mm woven Dacron (Dupont, 
Whington, DE) graft. I d o w  and outflow cannulae are 
partially velour-covered, and accurate adjustment at 
the exit sites to allow for tissue ingrowth, which decreases 
the potential for ascending infection of the mediastinum, is 
important. 
The patient is prepared and draped in a standard 
fashion for CPB. The groin is prepared for femoral 
vascular access in patients with previous open heart 
surgery. One outflow graft is prepared when univentricular 
support is planned, and two are prepared if biventricular 
support is anticipated. We soak the Dacron portion of the 
outflow cannulae in 25% albumin and autoclave for 3 to 
4 minutes at 83°C. Another approach is to preclot the 
outflow graft in 100 mL of nonheparinized blood mixed 
with 5 mg protamine and 5,000 U of topical thrombin. 
Regardless, care is taken not to get material inside the 
graft. The VAD is filled with 5% albumin with 100 U 
heparid250 mL, which passivates the surface and 
enhances removal of air later. The electrical connector 
on the driveline is covered with a finger cut from a 
sterile glove to protect it from fluids, and the inlet and 
outlet ports are plugged with silicone rubber stoppers. 
Transesophageal echocardiography (TEE) is used con- 
tinuously to search for a patent foramen ovale (PFO) 
(which must be closed to prevent right-to-left shunting/ 
hypoxia/cyanosis), aortic insufficiency, air, cannula 
position, RV function, and LV or atrial thrombus. 
Significant aortic insufficiency must be corrected and 
sought for just as a PFO after the LV end-diastolic 
pressure has been lowered by assist pumping. 
Aortic cannulation sutures are made in a standard 
fashion as high as possible on the inner curvature of the 
ascendmg aorta or transverse arch. A standard two-staged 
venous cannula through the right atrial appendage is 
used for venous return. Full CPB without active cooling 
is instituted. The aorta is not cross-clamped. Standard 
full-dose aprotinin is used to decrease bleeding, blood, 
and blood product usage and subsequent RV failure. 
The VAD comes with a black collet and colletnut on 
the valve housing of the inflow VAD. This black collet 
and colletnut should always be used with the inflow 
atrial cannulae. Although the ventricular inlet cannulae 
can be cut to length, do not cut the atrial cannulae. 
When LV or RV cannulation is planned, remove the 
black colletnut and collet from VAD inflow housing. 
Only the white colletnut and collet packaged with the 
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ventricular inlet cannula can be used for coupling to the 
inflow valve housing. The different collets and collet- 
nuts are necessary because of the wall thickness of the 
respective cannulae. Using the wrong collets and collet- 
nuts can result in the disasterous complication of pump 
disconnect! Proper selection of the percutaneous exit 
site is critical to allow the heart to lie in its anatomical 
position and to prevent kinking of the cannulae, as well 
as discomfort to the patient. The lateral of the skin 
incisions should generally be in the mid-clavicular line 2 
to 3 cm below the subcostal margin on the right or  left 
side, depending on the planned procedure. The medial 
incision should be approximately 4 cm from, and 
parallel to, the lateral incision. The skin incisions for 
inflow grafts should correspond well with cannulation 
sites on the heart in the pericardial well. The skin 
incisions should be as tight as possible to allow tissue 
ingrowth. Generally, there should be about 6 to 7 cm of 
cannula above skin level, including 2 cm of velour. If 
shorter than this, it is difficult to connect to the VAD, 
and if longer than this, kinking and discomfort can be a 
problem. The cannulae should be affixed to the skin 
with heavy nonabsorbable suture, which are left in 
place for 2 weeks, postoperatively. This limits motion 
and allows for tissue ingrowth. We have developed 
several instruments to facilitate operative insertion (Fig 
VI). These will soon be available in a commercial form 
from Thoratec (Pleasanton, CA). 
SURGICAL TECHNIQUE: 
LVAD-VENTRICULAR CANNULATION 
1-1 Exit site and tunneling for LV cannulae. Perform median 
sternotomy. Prepare for CPB and VAD insertion according to 
previous section. Make a skin incision (button, 1.5 cm wide) 
approximately in the left mid-clavicular line 2 to 3 cm below the left 
subcostal margin, which should correspond with the LV apex in the 
pericardial well. The electrocautery is used to divide the subcutane- 
ous tissue, upper fascia, and rectus muscle. Stop when the lower 
fascia is reached. Bring tunneler through the incision within the 
rectus sheath beneath the costal margin into the diaphragmatic 
pericardium. The tunneler is brought into the pericardium after an 
incision is made with the electrocautery. 
1-2 Placeiiieiit of apical ventricidar sutures. EX- 
pose the apex by placing two to three laparatomy pads 
underneath and lateral to the apex. -4 sling can be 
made from a laparatomy pad and passed under the LI7 
aiid pulled and fixated to facilitate expoh~ire further. 
Palpate the apical dimple about 2 cm lateral to the left 
anterior descending. Eight to 1% 2-0 nonabsorbable 
sutures huttressed with felt are passed radially full- 
thickness through the apical LY muscle around the 
apical dimple. Once the first two to four sutures are in 
place. thej can be used for bringing the ventricular 
apex tip further in the field for exposure. 
I 
1-3 Coring of the apex. The patient is placed in the 
Trendelenburg position; a stab incision is made in the center of 
the circle created by the suture placement. .4 large Foley 
catheter, with a 3o-mL balloon, is passed through the lumen of 
a sharpened cork borer (12 to 14 mm); the Foley catheter is 
inserted into the stab incision and the balloon inflated with 
saline. The sharpened cork borer is lowered into position. The 
Foley balloon is used as an anvil. A core of myocardial apex is 
excised. The Foley catheter is deflated aiid removed, and the 
inside of the LV cavity is inspected for thrombus or large 
trabeculae that need to he removed. 
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1-4 Cannula insertion and fixation. The ventricu- 
lar cannula is inserted. The combination cannula plug/ 
suction connector is inserted into the distal end of the 
cannula and is affixed to cardiotoiny suction. This 
ventilates the LV while sutures are passed through the 
sewing ring and tied. We prefer the blunt-tip velour- 
covered cannula. The inflow cannulation site must be 
absolutely hemostatic, and care must be taken during 
suture placement and tying, particularly in the face of 
recent myocardial infarction. 
i 
1-5 Inflow tunneling to the exit site. The end of the inflow 
cannula is plugged with the cap of the combination cannula 
plug/suction connector, making sure that air is absent, and the 
cannula is then passed out through the tunneler. The tunneler is 
removed. A cardiotomy suction line is once again connected to the 
combination cannula plug/suction connector after removing the 
screw-on cap for continued venting and deairing. 
1-7 Outflow graft aortic anastomosis. The outflow cannula- 
tion site for patients being considered for bridge-to-transplantation 
is along the greater curvature of the ascending aorta as low as 
safely possible to allow for removal of the graft site at the time of 
recipient cardioectomy. The cannulation site for the postcardi- 
otomy group of patients is dictated by the presence of proximal 
vein-graft anastomoses. A partial occluding clamp is placed on the 
ascending aorta, and a longitudinal aortotomy is made. The graft is 
sewn in an end-to-side fashion using a running 4-0 polypropylene 
suture that is reinforced with a strip of felt or pericardium. The 
partial clamp is removed from the aorta, and the Dacron graft is 
clamped with a soft vascular clamp close to the aortic anastomosis. 
Check for hemostasis and a need for additional sutures. 
1-6 Exit site and tunnel for outflow graft. The outflow graft 
is measured to the appropriate length, and the Dacron graft is 
cut, beveled, and trimmed. The graft should be long enough to be 
able to be directed under the right half of the sternum in order to 
be protected when reentering the chest but should be short 
enough to prevent kinking. 4 second skin button is made 4 cm 
toward the midline, parallel to the inflow cannula incision. The 
tunneler is brought through the incision as before to the diaphrag- 
matic perirardial surface and is left in plare. 
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I -8 Final preparation for connection. The outflow 
graft is brought through the tunneler and the tunneler is 
removed. There should now be about 6 cm of out- and 
inflow cannula above skin level including 1 to 2 cm of 
velour. If any of the cannulae are too long, they can now be 
cut. The soft clamp is removed from the outflow graft, is 
allowed to fill with blood, and is deaired, and a tubing clamp 
is applied distal to the velour. The combination cannula 
plug/suction connector is removed from the inflow graft and 
is clamped distal to the velour. 
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1-9 Connection of inflow graft to VAD. The silicone stopper is removed from inflow 
VAD housing. Verify proper VAD pump alignment with arrows on inlet and outlet valve 
housing. Advance the apical cannula along the cone-shaped valve housing until the 
cannula edge is all the way into the connector groove. This can be done carefully with two 
small hemostats and a “peanut.” Slide the collet and colletnut over the inflow cannula as 
far as possible and then hand tighten the colletnut. 
1 10 Connection of the outflow graft to the VAD and 
initial deairiiig. R e m o ~  e the tu1)ing clanil) from the inflow graft 
and allow the heart to fill with blood. Rotate the table toward 
the patient’s left d e  and tilt the V i D  toward the left so that the 
remaining air can he flushed out through the VA4D oiitflow port 
after removal of the silicone stopper. Put a soft jaw vascular 
clamp on the Dacron portion of the outflow graft near the aortic 
anastomosis and remove the tubing clamp; slow hackbleeding 
will occur. Shake the TAD to tleair, noting that many times. 
there is air trapprd below the outflow valve. Place the patient in 
the reverse Trendelenburg position. Connect the outflow ran- 
nula to the VAD as c1esi~ribr.d previously while flooding the 
connection with heparinized saline. 
1-1 1 Final deairing and VAD initiation. Place a needle into 
the Dacron graft in a high spot, and, optionally, the ascending aorta 
may be vented a5 well. Remove the glove protector from the 
Y-pneumatic driveline/electrical connector and attach the pneu- 
matic and electrical lead. Place the patient in the Trendelenhurg 
position, start handpumping the VAD slowly, and check for air in the 
VAD housing and inlet and outlet cannulae and for hemostatic 
proprrties of suture lines. Check for residual air in the aorta o r  left 
heart with TEE. Remove the soft jaw clamp from the outflow graft 
and hand pump again. Connect lead to console and begin console 
operation. Gradually increase the VAD rate as CPB is cliscontinuecl. 
Provide the usual management of right heart dysfunction including 
inotropes, nitric oxide, volume, and pacing. Satisfactory pumping is 
cardiac index (CI) > 2.2 L/min/ni, left atrial pressure (LA) < 15 inin 
Hg, and central venous pressure (CVP) < 15 mm Hg. Do not apply 
pump vacuum until the chest is closed. Careful measurement of 
filling pressure$, cardiac output, ant1 TEE will cm&mi satiifactory 
operation or indicate inlet cannula obstruction requiring reposition- 
ing or right heart failure requiring a second device. 
LVAD-ATRIAL CANNULATION 
2- 1 Left atrial appendage. This is not an optimal inflow cannnlation site 
when circumflex vein grafts are present becanse of the risk of vein-graft 
compression. Determine if a long or short atrial inflow cannula is to be used 
(in most patients the long right-angled one is best fitted). Appropriate 
ineasurenient is important because the inflow cannula cannot be trimmed to 
length. The black colletnut and collet are used. The VAD rests on the anterior 
a1)tloininal wall to the left as in LV apical cannulation. and the exit sites aiid 
skin buttons are made in the same fashion (see 1-4). Make the lateral skin 
button and incision and tunnel the atrial inflow cannula to its target site in 
the pericardium near the left atrial appendage. This is a fixed position. 
Prepare the outflow graft by measuring it, then cut and bevel the Dacron 
part. Make the exit site for the site for the outflow graft and leave the 
tnnneler in place. 
Retract the heart to the patient‘s right side, exposing the left atrial 
appendage. Place two 3-0 polypropylene purse-string sutures at the base of 
the appendage. Each bite of suture on the appendage surface is brought in 
and out of sinall felt pledgets. Leave sutures long and pass them through 
rubber tube keepers. This facilitates removal later. Incise the appendage in 
the center of purse string aiid dilate the opening. Make sure the atrial 
cannula is claniped and insert it approximately 4 cin from the end of the tip. 
Single- and double-line niarlters arr  5 and 6 ciii from the tip. Tighten the 
ruhl)er lteepers and tie tlirin over polypropylene hnttonr. Secure the cannula 
h j  tying a tape ligature around each keeper ant1 the cwniula. The distal end 
of the cannula is plugged with a conil~ination cannula plug/suction coniiertor. 
which is then twnnectetl to rardiotoiriy suction. Proceed with aortic anastomo- 
sis. i n f l o w  connection, outflo\+ connection. and tleairing as in LV apical 
cannulation. Confirm position with TEE. 
2-2 Interatrial groove. Determine which atrial inflow cannula is to be 
used; for most patients, the long one is most appropriate. Measurement is 
important because, once again, the cannula cannot be trimmed to length. The 
black colletnut and collet are used. With this inflow cannula placement. the 
VAD will be to the right of the midline and upside down, with the fill switch 
side against the abdomen as shown in 1-2. 
Make the lateral skin button and incision and tunnel the atrial inflow 
cannula to its target site by the interatrial groove. This is a fixed position. 
Prepare the outflow graft by measuring it, then cut and bevel the Dacron 
part. Make the exit site for the outflow graft and leave the tunneler in place. 
Retract the heart to the left side. Place two 3-0 polypropylene purse-string 
sutures along the interatrial groove between the right superior and inferior 
pulmonary vein. Each bite of the suture on the epicardial surface is brought 
in and out of sniall felt pledgets. Leave sutures long and pass them through 
rubber tube keepers. The cannula should never be inserted directly into a 
pulmonary vein because of potential stasis and thrombosis. Incise in the 
center of purse string and dilate. Make sure the atrial cannula is clamped and 
insert it 4 cm pointing toward the mitral valve. Secure and tighten as 
described for left atrial appendage cannulation. Proceed with the rest as 




3- 1 Right atrial cannulation. The RVAD placement and orientation is 
determined by the mode of support (uni- or biventricular) and the LVAD 
inflow cannulation site (see 1-1, 1-2, and 1-3). Determine which atrial 
cannula is to be used (usually the short one in the bridge-to-transplant 
application). Once again, measurement is important because atrial inflow 
cannulae cannot be trimmed to length. The black collet and colletnut are 
used. Place the curved portion of the atrial cannula next to the right atrial 
appendage and approximate the skin exit. Make a skin button and 
incision; tunnel the atrial inflow cannula to its target site by the right 
atrium. Prepare the outflow graft by measuring it to pass over the RV to 
the pulmonary artery, then cut and bevel the Dacron part. Make the exit 
site for the outflow graft and leave the tunneler in place. Place two 3-0 
polypropylene purse-string sutures with felt (as described for the left 
atrial cannulation) in the body of the right atrium opposite the tricuspid 
valve. Make a stab wound in the center of the purse string and dilate. 
Insert the atrial cannula 4 cm toward the tricuspid valve. Tighten keepers 
and secure as described for left atrial cannulation. The pulmonary artery 
is gently elevated, and a partial occluding clamp is applied above the level 
of the valve. When on CPB, the anastomosis can be performed without a 
partial-occluding clamp. A longitudinal arteriotomy is made in the 
pulmonary artery. A running end-to-side anastomosis with 4-0 polypropyl- 
ene is made and optionally reinforced with felt or pericardium. The 
Dacron graft is clamped with a soft vascular clamp 5 to 10 cm above the 
anastomosis, and the partial-occluding clamp on the pulmonary artery is 
removed. The graft is brought out through the tunneler. Proceed as 
described for LV cannulation after the aortic anastomosis is performed. 
Confirm position with TEE. 
THORATEC PARACORPOREAL PKEI MATIC VAD 367 
3-2 RV cannulation. The RVAD is placed to the right 
of the midline, and the ventricular inflow cannula will be 
the medial of the skin exits (see 1-3). The inflow cannula 
(same as used for the LV apical cannulation) enters the RV 
through the diaphragmatic wall, superior to the posterior 
descending artery. TEE can be helpful in determining the 
best location for placement of the cannula. The tip of the 
ventricular cannula is directed toward the tricuspid valve 
to optimize inflow into the RVAD. We prefer this method in 
the bridge-to-transplant application, because flows seem 
to be higher. 
Place the apical cannula tip next to the chosen cannula- 
tion site and estimate the skin exit site. Make the skin 
button and incision. Bring the tunneler through to the 
pericardial space and leave it in place. Expose the cannu- 
lation site by using laparotomy pads as described for the 
LV apical cannulation. Place 8 to 12 pledgeted 2-0 sutures 
on the diaphragmatic surface of the right ventricle. A 
purse-string suture can be placed through the pledgets to 
provide additional hemostasis (the RV wall is thin in this 
location). The remainder of the insertion is as described 
for the LV apical cannulation except that the outflow graft 
is attached to the pulmonary artery and the skin exit site is 
the lateral of the two. 
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CONCLUSION 
After nearly 25 years of experience with this device, we 
feel that the key to successful outcomes is based 
primarily on patient selection combined with early 
implantation. Operative strategy has been standard- 
ized. According to the Thoratec voluntary registry, over 
1,000 patients have been implanted with this device. 
Nearly 35% of the patients received biventricular 
support in the recovery application, postcardiotomy, 
and 62% received support in the bridge-to-transplant 
group. Postcardiotomy results have always been some- 
what disappointing but expected, with 38% to 48% of 
patients being weaned from support and about one half 
of those weaned being discharged from the hospital. 
Our own individual institutional results, as well as those 
reported from a wider voluntary registry, are very 
~ i m i l a r . ~ ? ~  In the bridge-to-transplant application, Tho- 
ratec registry results report a transplant rate, overall, 
of 61%, with 83% of the biventricular support patients 
discharged after transplant and 93% of the LVAD 
patients discharged after transplant. Major adverse 
events include reoperation for bleeding (10% LVADs, 
32% biventricular [VADs], device-related infection 
(13%), and embolic stroke (5%) .  Institutional reports, 
as well as voluntary registry reports, indicate compa- 
rable results.6-11 We recently reviewed our last 86 
consecutive patients who received circulatory support 
with the intent to bridge-to-transplantation. l2 Thirty- 
three patients received this Pierce-Donachy-type de- 
vice from 40 to 150 days while awaiting transplantation. 
Bleeding that required reoperation was seen in 21% of 
these 33. Device-related infection was seen in 3% of 
these, and 8 of the patients (24%) had neurological 
events. One half of these events were nonfatal and left 
no neurological residua. Thromboembolic events oc- 
curred more frequently in patients with recent acute 
myocardial infarction and in patients with left atrial 
inflow cannulation. These likely account for the differ- 
ence between our series and that reported by Thoratec. 
Seventy percent of our patients underwent orthotopic 
cardiac transplantation, and 91% of those transplanted 
were discharged and are still doing well. 
We firmly believe that a variety of devices should be 
available to accommodate the patient, not the converse. 
The Thoratec device provides a versatile system for 
multimodal inlet cannulation, biventricular support, 
and use in the small patient. It also provides a cost 
advantage, with a minimal change in the quality of life 
when used with the portable driving system patients 
who are expected to have short waits for donor organs 
in the bridge-to-transplant application. Postcardi- 
otomy, there is no need for immediate intense anticoagu- 
lation. Furthermore, the device can be used for ex- 
tended periods of time. Device changeover in the event 
of nonrecovery and transplant candidacy is unneces- 
sary. Overall reliability has been excellent, and clinical 
results have been quite commendable and comparable 
to other available pump designs. 
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